200 related articles for article (PubMed ID: 19114568)
1. Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders.
Clark RE; Samnaliev M; McGovern MP
Psychiatr Serv; 2009 Jan; 60(1):35-42. PubMed ID: 19114568
[TBL] [Abstract][Full Text] [Related]
2. Medicaid Expenditures for Fee-for-Service Enrollees with Behavioral Diagnoses: Findings from a 50 State Claims Analysis.
Ward MC; Lally C; Druss BG
Community Ment Health J; 2017 Jan; 53(1):1-7. PubMed ID: 27306989
[TBL] [Abstract][Full Text] [Related]
3. Risk adjustment alternatives in paying for behavioral health care under Medicaid.
Ettner SL; Frank RG; McGuire TG; Hermann RC
Health Serv Res; 2001 Aug; 36(4):793-811. PubMed ID: 11508640
[TBL] [Abstract][Full Text] [Related]
4. Growth in Spending on and Use of Services for Mental and Substance Use Disorders After the Great Recession Among Individuals With Private Insurance.
Mark TL; Hodgkin D; Levit KR; Thomas CP
Psychiatr Serv; 2016 May; 67(5):504-9. PubMed ID: 26725293
[TBL] [Abstract][Full Text] [Related]
5. The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state.
Wickizer TM; Krupski A; Stark KD; Mancuso D; Campbell K
Milbank Q; 2006; 84(3):555-76. PubMed ID: 16953810
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of psychiatric disorders and costs of care among adult enrollees in a Medicaid HMO.
Thomas MR; Waxmonsky JA; Gabow PA; Flanders-McGinnis G; Socherman R; Rost K
Psychiatr Serv; 2005 Nov; 56(11):1394-401. PubMed ID: 16282258
[TBL] [Abstract][Full Text] [Related]
7. Treatment for co-occurring mental and substance use disorders in five state Medicaid programs.
Clark RE; Samnaliev M; McGovern MP
Psychiatr Serv; 2007 Jul; 58(7):942-8. PubMed ID: 17602010
[TBL] [Abstract][Full Text] [Related]
8. Effect of eliminating behavioral health benefits for selected medicaid enrollees.
McConnell KJ; Wallace NT; Gallia CA; Smith JA
Health Serv Res; 2008 Aug; 43(4):1348-65. PubMed ID: 18384360
[TBL] [Abstract][Full Text] [Related]
9. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
10. The implementation of managed behavioral healthcare in Colorado and the effects on older Medicaid beneficiaries.
Kaskie B; Wallace N; Kang S; Bloom J
J Ment Health Policy Econ; 2006 Mar; 9(1):15-24. PubMed ID: 16733268
[TBL] [Abstract][Full Text] [Related]
11. Medicaid expenditures on behavioral health care.
Mark TL; Buck JA; Dilonardo JD; Coffey RM; Chalk M
Psychiatr Serv; 2003 Feb; 54(2):188-94. PubMed ID: 12556599
[TBL] [Abstract][Full Text] [Related]
12. Behavioral disorders and diabetes-related outcomes among Massachusetts Medicare and Medicaid beneficiaries.
Leung G; Zhang J; Lin WC; Clark RE
Psychiatr Serv; 2011 Jun; 62(6):659-65. PubMed ID: 21632736
[TBL] [Abstract][Full Text] [Related]
13. Impact of Medical Homes on Expenditures and Utilization for Beneficiaries With Behavioral Health Conditions.
Romaire MA; Keyes V; Parish WJ; Kim K
Psychiatr Serv; 2018 Aug; 69(8):871-878. PubMed ID: 29759058
[TBL] [Abstract][Full Text] [Related]
14. Decomposing Medicaid Spending During Health System Reform and ACA Expansion: Evidence From Oregon.
Renfro S; Lindner S; McConnell KJ
Med Care; 2018 Jul; 56(7):589-595. PubMed ID: 29762274
[TBL] [Abstract][Full Text] [Related]
15. Association of copayments with healthcare utilization and expenditures among Medicaid enrollees with a substance use disorder.
Lazic A; Tilford JM; Davis VP; Brown CC
J Subst Use Addict Treat; 2024 Jun; 161():209314. PubMed ID: 38369244
[TBL] [Abstract][Full Text] [Related]
16. Mental health spending by private insurance: implications for the mental health parity and addiction equity act.
Mark TL; Vandivort-Warren R; Miller K
Psychiatr Serv; 2012 Apr; 63(4):313-8. PubMed ID: 22476300
[TBL] [Abstract][Full Text] [Related]
17. Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care.
Dickey B; Azeni H
Am J Public Health; 1996 Jul; 86(7):973-7. PubMed ID: 8669521
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic drug use and expenditures among medicaid beneficiaries with and without other mental health or substance abuse services.
Hennessy KD; Green-Hennessy S; Buck JA; Miller K
J Nerv Ment Dis; 2003 Jul; 191(7):476-8. PubMed ID: 12891096
[No Abstract] [Full Text] [Related]
19. Effects of Medicaid disease management programs on medical expenditures: Evidence from a natural experiment in Georgia.
Kranker K
J Health Econ; 2016 Mar; 46():52-69. PubMed ID: 26851876
[TBL] [Abstract][Full Text] [Related]
20. Do adjusted clinical groups eliminate incentives for HMOs to avoid substance abusers? Evidence from the Maryland Medicaid HealthChoice program.
Ettner SL; Johnson S
J Behav Health Serv Res; 2003; 30(1):63-77. PubMed ID: 12633004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
